GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Express Scripts Holding Co (NAS:ESRX) » Definitions » Research & Development

Express Scripts Holding Co (Express Scripts Holding Co) Research & Development : $0 Mil (TTM As of Sep. 2018)


View and export this data going back to 1992. Start your Free Trial

What is Express Scripts Holding Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Express Scripts Holding Co's Research & Development for the three months ended in Sep. 2018 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2018 was $0 Mil.

Express Scripts Holding Co Research & Development Historical Data

The historical data trend for Express Scripts Holding Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Express Scripts Holding Co Research & Development Chart

Express Scripts Holding Co Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Express Scripts Holding Co Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Express Scripts Holding Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Express Scripts Holding Co  (NAS:ESRX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Express Scripts Holding Co Research & Development Related Terms

Thank you for viewing the detailed overview of Express Scripts Holding Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Express Scripts Holding Co (Express Scripts Holding Co) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Express Scripts Holding Co (NAS:ESRX) » Definitions » Research & Development
Comparable Companies
HUM ANTM CI CNC WCG MOH BSP:GNDI3 CVS BSP:QUAL3 BSP:ODPV3 MGLN HQDA GTS HIIQ ROCO:6665 MIL:HI OSTO:FEEL TSXV:META PFHO TSXV:NXG
Traded in Other Exchanges
N/A
Address
Website
http://www.express-scripts.com
Express Scripts is the largest pharmacy benefit manager in the United States. Through its mail-order pharmacy and network of retail pharmacies, Express Scripts processes approximately 1.3 billion adjusted prescriptions annually for its payer clients.